根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-09-30 AccNo: 0001437749-19-019273 Size: 1 MB 网页链接
$Isoray(ISR)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-09-27 AccNo: 0001437749-19-019176 Size: 7 MB 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-09-24 AccNo: 0001437749-19-018962 Size: 203 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-08-05 AccNo: 0001437749-19-015485 Size: 89 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-07-24 AccNo: 0001437749-19-014549 Size: 104 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrang...
$Isoray(ISR)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001437749-19-013981 Size: 20 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-06-24 AccNo: 0001437749-19-012546 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Isoray(ISR)$ 8-K - Current report Filed: 2019-05-28 AccNo: 0001437749-19-010903 Size: 44 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Isoray(ISR)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-05-13 AccNo: 0001437749-19-009660 Size: 886 KB 网页链接
$Isoray(ISR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-10 AccNo: 0001437749-19-009498 Size: 3 MB 网页链接